Paul Feldman
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Paul L.
Feldman is the founder of Phoundry Pharmaceuticals, Inc., founded in 2015, where the title held is Chief Executive Officer & Director.
Current jobs include Director at Chordoma Foundation and Chief Scientific Officer at Aktis Oncology, Inc. since 2020.
Education history includes undergraduate studies at Duke University and a doctorate from the University of California, Berkeley.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. 0,22% | 09/01/2026 | 118 283 ( 0,22% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/12/2020 |
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Fondateur | 01/01/2015 |
Chordoma Foundation
Chordoma Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that accelerates research to develop better treatments and a cure for the rare bone cancer chordoma | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Health Technology |
Chordoma Foundation
Chordoma Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that accelerates research to develop better treatments and a cure for the rare bone cancer chordoma | Commercial Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national